Literature DB >> 31037465

Antidepressant and Neuroprotective Effects of Naringenin via Sonic Hedgehog-GLI1 Cell Signaling Pathway in a Rat Model of Chronic Unpredictable Mild Stress.

Mohd Tayyab1, Shirin Farheen1, Mubeena Mariyath P M1, Nabeela Khanam1, M Mobarak Hossain1,2, Mehdi Hayat Shahi3.   

Abstract

Depression is one of the most prevalent and crucial public health problem connected to significant mortality and co-morbidity. Recently, numerous studies suggested that dietary flavanones exhibit neuroprotective and antidepressant effects against various psycho-physiological conditions including depression. The present study is focused on the antidepressant and neuroprotective effects of naringenin (NAR) and the involvement of sonic hedgehog (Shh) signaling in the chronic unpredictable mild stress (CUMS)-induced depression. Twenty-four male Wistar rats were randomly assigned into four groups: CON group (saline s.c.), NAR group (NAR 50 mg/kg, p.o.), CUMS group (subjected to CUMS along with saline p.o.), and CUMS + NAR group (NAR 50 mg/kg p.o. along with CUMS) for 28 days including 1-week pre-treatment with NAR. The results showed that NAR was found to inhibit behavioral abnormalities including increased despair in force swim test, and reduced locomotor activity caused by CUMS in open field test. Moreover, Morris water maze revealed that NAR also mitigates CUMS-associated cognitive impairment. In addition to the antidepressant-like effect, NAR mitigates morphological anomalies in the hippocampal CA1 region and cortex. Furthermore, we observed brain-derived neurotrophic factor (BDNF), Shh, GLI1, NKX2.2, and PAX6 were downregulated in the hippocampus of CUMS-exposed rats, which can be upregulated by NAR pre-treatment. GLI1 is main downstream signaling component of Shh signaling cascade, which further regulates the expression of homeodomain transcription factors PAX6 and NKX2.2.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Depression; Hippocampus; Memory; Sonic hedgehog

Mesh:

Substances:

Year:  2019        PMID: 31037465     DOI: 10.1007/s12017-019-08538-6

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  55 in total

Review 1.  Human emotion and memory: interactions of the amygdala and hippocampal complex.

Authors:  Elizabeth A Phelps
Journal:  Curr Opin Neurobiol       Date:  2004-04       Impact factor: 6.627

Review 2.  Chronic mild stress-induced anhedonia: a realistic animal model of depression.

Authors:  P Willner; R Muscat; M Papp
Journal:  Neurosci Biobehav Rev       Date:  1992       Impact factor: 8.989

3.  Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.

Authors:  Virginia Zbarsky; Krishna P Datla; Shabnam Parkar; Deepal K Rai; Okezie I Aruoma; David T Dexter
Journal:  Free Radic Res       Date:  2005-10

4.  Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions.

Authors:  Janne Grønli; Robert Murison; Eldbjørg Fiske; Bjørn Bjorvatn; Eli Sørensen; Chiara M Portas; Reidun Ursin
Journal:  Physiol Behav       Date:  2005-03-31

5.  Hippocampal volume reduction in major depression.

Authors:  J D Bremner; M Narayan; E R Anderson; L H Staib; H L Miller; D S Charney
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

6.  Recruitment of the Sonic hedgehog signalling cascade in electroconvulsive seizure-mediated regulation of adult rat hippocampal neurogenesis.

Authors:  Sunayana B Banerjee; Rajeev Rajendran; Brian G Dias; Uma Ladiwala; Shubha Tole; Vidita A Vaidya
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

Review 7.  New approaches to antidepressant drug discovery: beyond monoamines.

Authors:  Olivier Berton; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

8.  Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment.

Authors:  Jessica E Malberg; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2003-07-02       Impact factor: 7.853

9.  Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress.

Authors:  Li Song; Wang Che; Wang Min-Wei; Yukihisa Murakami; Kinzo Matsumoto
Journal:  Pharmacol Biochem Behav       Date:  2006-03-06       Impact factor: 3.533

10.  Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection.

Authors:  Ho Jin Heo; Dae-Ok Kim; Soo Cheol Shin; Mi Jeong Kim; Byung Gee Kim; Dong-Hoon Shin
Journal:  J Agric Food Chem       Date:  2004-03-24       Impact factor: 5.279

View more
  5 in total

1.  Structural Characterization and Anti-inflammatory Activity of a Galactorhamnan Polysaccharide From Citrus medica L. var. sarcodactylis.

Authors:  Bi Luo; Jia Lv; Kejie Li; Peiran Liao; Peng Chen
Journal:  Front Nutr       Date:  2022-06-09

Review 2.  Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols.

Authors:  Arslan Iftikhar; Rimsha Nausheen; Humaira Muzaffar; Muhammad Ahsan Naeem; Muhammad Farooq; Mohsin Khurshid; Ahmad Almatroudi; Faris Alrumaihi; Khaled S Allemailem; Haseeb Anwar
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

3.  Optimization of food deprivation and sucrose preference test in SD rat model undergoing chronic unpredictable mild stress.

Authors:  Li-Wen He; Li Zeng; Na Tian; Yi Li; Tong He; Dong-Mei Tan; Qian Zhang; Yi Tan
Journal:  Animal Model Exp Med       Date:  2020-03-31

4.  Dietary Intake of Flavonoids and Carotenoids Is Associated with Anti-Depressive Symptoms: Epidemiological Study and In Silico-Mechanism Analysis.

Authors:  Seon-Joo Park; Varun Jaiswal; Hae-Jeung Lee
Journal:  Antioxidants (Basel)       Date:  2021-12-27

5.  Therapeutic Targets and Mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study.

Authors:  Ze Chang; Li-Juan He; Dang-Feng Tian; Qiang Gao; Jing-Feng Ling; Yu-Chun Wang; Zhen-Yun Han; Rong-Juan Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.